基本信息
浏览量:68

个人简介
Prof Ulrika Simonsson leads research related to tuberculosis drug development and optimized individual dosing using innovative pharmacometric methods. She has been leading the modeling and simulation efforts within the IMI funded consortium PreDiCT-TB compromising 21 academic and industrial partners. She is now a partner of the IMI funded consortium ERA4TB, a consortium aiming in identifying and characterising new drugs against tuberculosis.
研究兴趣
论文共 123 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Veronique de Jager,Laurynas Mockeliunas, Huifang You,Ulrika S H Simonsson, Tarryn Collings, Caryn M Upton, Johannes A Bezuidenhout,Nikhil Gupte,Susan Dorman, Eric Nuermberger,Gyanu Lamichhane, Andreas H Diacon, Kelly E Dooley
Clinical infectious diseases an official publication of the Infectious Diseases Society of America (2025)
Diana A. Aguilar-Ayala,Fernando Sanz-Garcia,Marie Sylvianne Rabodoarivelo,Budi O. Susanto,Rebeca Bailo, Maxime R. Eveque-Mourroux,Nicolas Willand,Ulrika S. H. Simonsson,Santiago Ramon-Garcia,Ainhoa Lucia
BRITISH JOURNAL OF CLINICAL PHARMACOLOGYno. 7 (2024): 1711-1727
Nitya Krishnan,Miles Priestman,Iria Uhia, Natalie Charitakis, Izabella T. Glegola-Madejska,Thomas M. Baer, Albin Tranberg,Alan Faraj,Ulrika S. H. Simonsson,Brian D. Robertson
PLoS Biologyno. 8 (2024): e3002766-e3002766
CLINICAL PHARMACOLOGY & THERAPEUTICSno. 3 (2024): 498-505
ADVANCES IN THERAPYno. 9 (2023): 3739-3750
FRONTIERS IN PHARMACOLOGY (2023)
加载更多
作者统计
#Papers: 123
#Citation: 2913
H-Index: 30
G-Index: 49
Sociability: 6
Diversity: 3
Activity: 25
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn